Wearable medical technologies are transforming clinical decision-making by enabling more accurate, data-driven patient care. SocketSense aims to improve prosthetic socket fitting through a thin, flexible pressure-mapping system that provides real-time measurements of load distribution between a patient’s residual limb and prosthetic socket. By replacing subjective fitting methods with objective pressure data, the technology has the potential to improve patient comfort while reducing costly refitting procedures for clinicians.

This report evaluates whether SocketSense represents a compelling venture capital opportunity by examining the size, growth, and accessibility of its target market. Using a TAM–SAM–SOM framework, the analysis estimates a €44 million European addressable market, a €4.4 million serviceable market, and a realistic five-year serviceable obtainable market of approximately €942,000. Long-term demand is supported by rising global amputation rates, increasing prevalence of diabetes and vascular disease, and the growing adoption of digital healthcare technologies.

Beyond market opportunity, the report analyzes SocketSense’s business model and unit economics. The company combines high-margin hardware sales with recurring software subscriptions and consumable revenues, creating a scalable revenue model capable of generating attractive lifetime customer value. Financial projections suggest strong gross margins, favorable LTV:CAC dynamics, and a pathway to profitability supported by recurring software revenues and long-term customer retention.

The analysis also evaluates product-market fit, competitive positioning, and execution risk. SocketSense addresses a clearly defined clinical problem for which no widely adopted objective solution currently exists, while benefiting from potential first-mover advantages in pressure-mapping technology for prosthetic fitting. At the same time, regulatory approval requirements, clinical validation, reimbursement uncertainty, and adoption by healthcare providers remain key milestones that will determine commercial success.

Finally, the report outlines the company’s development roadmap, highlighting the progression from proof-of-concept and clinical validation to commercial deployment and the longer-term vision of building an AI-powered decision-support platform integrated into prosthetic care workflows. It concludes that SocketSense represents an attractive early-stage investment opportunity, provided the company successfully validates its technology, demonstrates clinical value, and establishes recurring revenue through hardware, software, and data-driven services.